about
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditionsPharmaceutical interventions for emotionalism after strokeBehaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis.Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population.Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affectPseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders.Diagnosing pseudobulbar affect in traumatic brain injury.Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosisPseudobulbar affect: an under-recognized and under-treated neurological disorder.Pseudobulbar affect: burden of illness in the USA.Pseudobulbar affect: prevalence and management.Persistent pseudobulbar affect secondary to acute disseminated encephalomyelitisEscitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.Involuntary emotional expression disorder (IEED) in Parkinson's diseaseTreatment of neuropsychiatric conditions associated with multiple sclerosis.Dextromethorphan/quinidine sulfate for pseudobulbar affect.Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residentsTelephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS).The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour.Current concepts in the pharmacotherapy of pseudobulbar affect.Behavioural symptoms and impairments in multiple sclerosis: a systematic review and meta-analysis.How is affective instability defined and measured? A systematic review.Depression and disease progression in amyotrophic lateral sclerosis: A comprehensive meta-regression analysis.An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.Neuronal Dysregulation in Stroke-Associated Pseudobulbar Affect (PBA): Diagnostic Scales and Current Treatment OptionsPseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP).Outcome measures in amyotrophic lateral sclerosis clinical trialsDextromethorphan and quinidine combination in emotional lability associated with depression: a case report.Laughter, crying and sadness in ALS.The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS.Adrenal dysregulation in amyotrophic lateral sclerosis.A survey of clinicians' practice in the symptomatic treatment of ALS.Behavioral Treatment of Pseudobulbar Affect: A Case Report.Apathy and its impact on patient outcome in amyotrophic lateral sclerosis.Inappropriate crying and laughing in Parkinson disease and movement disorders.Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis.
P2860
Q21132546-00F1E11F-EF5B-42D5-95A1-795C601FE6C7Q24240045-5F1C8C68-6FF0-48CD-B370-5D644590B7B1Q30460222-8604198A-5D46-4C6A-81CE-EC83CA72764AQ30524895-F4F96A22-3AA5-452C-99E7-36E1D543D408Q30634431-8AFBAFF1-E742-4D90-8FB5-A2E509615558Q30728028-7E4B791B-B623-458E-862E-1F6A97088494Q33838839-F1516DA7-230E-4EF2-A585-E25AB4B7B660Q34026748-98F200E0-8D50-47A4-94F0-C93A79D12515Q34079300-BBC20DBC-5A42-4E4C-BD0D-72C914152191Q34354384-BDF23414-F840-42E4-9093-F37B16B42ADEQ34418793-D566C0A8-611C-4E07-BC92-EB6119912939Q34630034-A48B4631-47BF-42CB-A3E5-C42468B66FB7Q34641967-46AF8924-A081-45EA-A86C-1CEA69DDBFD6Q34658447-F8281C08-1A6F-4A5F-89FC-B07B14E02BEDQ35196901-153ACA3A-C760-459A-9241-977162C163AFQ35567191-F85B9B84-6D52-4895-B66B-22B6FBA72299Q36045307-9754219E-C1D4-4A82-85E0-B8BC8F6B8058Q36473096-2D7F5954-01C3-41C2-961A-9F8F0F201329Q36641533-7D380116-36D7-4851-8B7B-46100FDDBFFFQ37366440-DD29CB3B-7265-4E30-AA5F-AAC0B5C466E7Q37561654-D7ECC53B-868C-4CDD-A21D-D078453CCB17Q37708635-B3ED6DA8-A72A-4A1E-91CC-BDB859185D8CQ37710112-C954A6C1-489D-420A-A6B3-FCEE73400028Q37895256-2D716897-9CDC-4D8D-87D0-7F251EC877CBQ37989889-AA0670C7-FBF3-4095-87F2-F5D1EE2D0B30Q38145505-0ADD4627-9064-40EC-BC57-446F0C98D756Q38207001-ADF5970D-1540-4CFF-9EF1-4B4E974B5DC6Q38401900-9B7C2D86-9922-4EF1-969D-4148B2A3E7F3Q38676032-DC33140A-61B1-49F8-BA2C-CE05FC54B3DBQ39530443-21ED8A89-277D-410D-85C6-1952207B3F78Q41837997-175BD832-AFFA-4FB7-9AB0-84AAD0D54972Q41971188-E19E7BA5-6CD6-40A0-ABB4-D6EE4BFE0D54Q42275960-E800D236-F474-4D11-95A3-B1F283670C93Q44563255-8C1E84CE-5FF2-432C-A668-4989F97102A1Q44823235-95B8B9D1-92EE-4B37-9AA7-671BE185BA2CQ46818444-3C087D95-0626-4DA6-B88A-9C95D7C875FDQ47439448-BFE70B0E-C52F-4A88-A8FE-6B74BD014202Q47692052-EE0D6ED5-B42F-4F14-BF59-80288AD7A309Q49109094-AE06723B-32C1-45F8-91CC-2E72BC238028Q49438915-B56FB5FF-1E2B-4C09-B2D1-DBF5D987138E
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A self report measure of affective lability
@ast
A self report measure of affective lability
@en
A self report measure of affective lability
@nl
type
label
A self report measure of affective lability
@ast
A self report measure of affective lability
@en
A self report measure of affective lability
@nl
prefLabel
A self report measure of affective lability
@ast
A self report measure of affective lability
@en
A self report measure of affective lability
@nl
P2093
P2860
P3181
P356
P1476
A self report measure of affective lability
@en
P2093
E J Kasarkis
L S Gresham
M B Bromberg
P2860
P3181
P356
10.1136/JNNP.63.1.89
P407
P577
1997-07-01T00:00:00Z